Skip to content

MYRIAD GENETICS INC

MYGN · XNAS

CIK 899923fmd_0MP6QC3QT4ECMZJ6WDRDNAX0EPManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jul 01, 2008 to Sep 30, 2026, 70 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written
0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).

Loading